Valuation
- Market cap
- 0
- Revenue TTM
- $0
- Net income TTM
- $0
- PE ratio
- 0.00
- Forward PE
- 44.24
- Profit margin
- 0.00%
- Debt to equity
- 0.00
Trading
- Volume
- 79,900
- Avg volume
- 267,114
- Day's range
- $38.47 – $39.13
- Shares out
- —
- Stochastic %K
- 67%
- Beta
- —
- Analysts
- Strong Sell
- Price target
- $46.00
Company profile
Galderma Group AG operates as a dermatology company worldwide. The company delivers a science-based portfolio of brands and services for the dermatology market, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. Its portfolio of flagship brands includes Azzalure, ALLUZIENCE, Dysport, Restylane, Restylane Skinboosters, Sculptra, Cetaphil, ALASTIN, Soolantra, Epiduo, Epiduo Forte, Di...
Show more
Galderma Group AG operates as a dermatology company worldwide. The company delivers a science-based portfolio of brands and services for the dermatology market, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. Its portfolio of flagship brands includes Azzalure, ALLUZIENCE, Dysport, Restylane, Restylane Skinboosters, Sculptra, Cetaphil, ALASTIN, Soolantra, Epiduo, Epiduo Forte, Differin, AKLIEF, Oracea, Metvix, NEMLUVIO, Relfydess, Benzac, and Loceryl in therapeutic dermatology. The company was founded in 1981 and is headquartered in Zug, Switzerland.
- Industry
- Drug Manufacturers - Specialty & Generic
- Sector
- Healthcare
- Phone
- 41 58 455 85 92
- Website
- https://www.galderma.com
- Address
- Zählerweg 10, Zug, Switzerland
Latest news
No headlines yet.
